The week in health tech, explained in plain English.Get the free newsletter →
November 18, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Kindergarten Vaccination Rates Slip Again as Exemptions Hit Record

Childhood vaccination coverage among US kindergartners declined again in the 2025-26 school year, according to new CDC data reported by Becker's Hospital Review. Coverage for the measles, mumps, and rubella (MMR) vaccine dropped to 92.4%, down slightly from 92.5% a year earlier and below the 95% threshold public health officials say is needed to prevent community spread.

The share of children claiming exemptions climbed to a record 4.2%, continuing a trend that has eroded coverage since the pandemic. When coverage falls under 95%, herd immunity weakens and the risk of outbreaks for diseases like measles rises, especially in pockets where exemption rates cluster well above the national average.

For hospitals and health systems, sustained declines translate into higher odds of vaccine-preventable outbreaks, added strain on pediatric and emergency capacity, and renewed pressure on public health agencies to rebuild confidence. The data underscores how far coverage has drifted from pre-pandemic norms and how difficult reversing the slide has become.

More in Government

Government

US Loses Measles Elimination Status After a Year of Spread

Global health authorities say the US has lost its measles elimination status after the disease spread continuously for over a year, ending a 25-year milestone.

Why it matters: Losing measles elimination status signals that a highly contagious, vaccine-preventable disease is again circulating freely in the U.S., threatening public health gains.

Government

Mark Cuban's Cost Plus to Develop US-Made Ibogaine for HHS

Mark Cuban Cost Plus Drug Co. will lead HHS-backed research to develop a US-made ibogaine product for PTSD and other mental illnesses, supported by up to $4.9 million.

Why it matters: Federal funding for domestically made ibogaine signals rising government interest in psychedelics for hard-to-treat conditions like PTSD in veterans.